SEC 13F Intelligence

Managers / Q4 2024 · view latest →

Exos Asset Management LLC

CIK 0001834630 · 35 W 35TH ST, FLOOR 5, NEW YORK, NY, 10001 · 6468140996

Reported Value
$433,434
Q4 2024
Positions
39
Filings on Record
14
2019–present window
Filed
Feb 13, 2025
original filing

Summary

Exos Asset Management LLC reported $433,434 in U.S.-listed holdings across 39 positions for Q4 2024.

Its largest position, Ares Acquisition Corp II, represents 14.0% of the portfolio.

Compared with Q3 2024, the fund opened 3 new positions and exited 22.

Portfolio Metrics

Turnover
+8.3%
vs prior filed quarter
Top-10 Concentration
+73.6%
share of reported value
Largest Position
+14.0%
Ares Acquisition Corp II
New / Exited
3 / 22
positions this quarter

Methodology: turnover is min(value bought, value sold) ÷ average reported value across the two quarters — value-based, so market moves inflate it slightly versus a share-based measure. Concentration and largest position are shares of the filing’s total reported value, options excluded, with multiple share classes and repeated sub-manager rows for the same issuer combined into one position — the same rule the holdings table uses by default. New/exited counts compare against the prior filed quarter. All figures derive solely from the fund’s 13F filings.

Reported Value by Quarter

13F Reported Value
Q4 ’20: $61MQ4 ’20Q1 ’21: $127MQ2 ’21: $193MQ2 ’21Q3 ’21: $190MQ1 ’22: $234MQ1 ’22Q2 ’22: $192MQ1 ’24: $169MQ1 ’24Q2 ’24: $87MQ4 ’24: $433,434Q4 ’24Q1 ’25: $2,319Q2 ’25: $0Q2 ’25Q3 ’25: $0filingsflow.com

Portfolio Composition

By security type
Other: 56.0%Equity WRT: 39.8%Common Stock: 4.2%
  • Other · 56.0% · $242,665
  • Equity WRT · 39.8% · $172,713
  • Common Stock · 4.2% · $18,056

Quarter-over-Quarter Changes full breakdown →

vs Q3 2024 (amended baseline)

IssuerMoveShare ΔShares nowValue ΔValue now
BAIRD MED INVT HLDGS LTDNEW+176.2K176.2K+$36,117$36,117
ALPHA MODUS HLDGS INCNEW+52.2K52.2K+$4,440$4,440
DEVVSTREAM CORPNEW+70.8K70.8K+$0$0
INFLECTION PT ACQUISITN CRPSOLD OUT−304.6K0−$72,763$0
SLAM CORPSOLD OUT−312.2K0−$46,824$0
ABACUS LIFE INCSOLD OUT−25.0K0−$42,500$0
EXCELFIN ACQUISITION CORPSOLD OUT−176.2K0−$26,286$0
FLDDWFTAC EMERALD ACQUISITION CORSOLD OUT−128.5K0−$25,700$0

Value changes conflate price moves with buying and selling — share changes are the real signal. Share counts are not split-adjusted.

Holdings — Q4 2024

39 positions
Export to Excel
#IssuerClass% PortfolioValue ↓Shares
1ARES ACQUISITION CORP II*W EXP 99/99/99914.04%$60,855405.7K
2LIFEZONE METALS LIMITED*W EXP 07/05/20211.49%$49,82067.7K
3BAIRD MED INVT HLDGS LTD*W EXP 10/01/2028.33%$36,117176.2K
4VEEA INC*W EXP 09/13/2028.29%$35,925224.5K
5SOUTHLAND HLDGS INC*W EXP 02/14/2028.26%$35,806149.2K
6VSEEWVSEE HEALTH INChistory →*W EXP 99/99/9995.63%$24,401489.0K
7VAST RENEWABLES LIMITED*W EXP 07/01/2025.58%$24,195320.5K
8STARDUST PWR INC*W EXP 06/21/2024.50%$19,51883.1K
9TLSITRISALUS LIFE SCIENCES INChistory →COM4.17%$18,0563.6K
10COCHWENVOY MEDICAL INChistory →*W EXP 09/29/2023.34%$14,478310.0K
11LAVORO LTD*W EXP 02/27/2022.26%$9,80875.1K
12CROWN LNG HLDGS LTD*W EXP 07/09/2022.12%$9,201295.8K
13SPWRWCOMPLETE SOLARIA INChistory →*W EXP 07/31/2022.05%$8,883102.1K
14NKGEN BIOTECH INC*W EXP 05/31/2022.04%$8,83588.4K
15JAWS MUSTANG ACQUISITION COR*W EXP 01/30/2021.85%$8,038321.5K
16COLISEUM ACQUISITION CORP*W EXP 08/22/2021.76%$7,625108.9K
17ISRAEL ACQUISITIONS CORP*W EXP 99/99/9991.75%$7,600180.9K
18AERIES TECHNOLOGY INC*W EXP 11/06/2021.17%$5,062144.6K
19ESGL HLDGS LTD*W EXP 10/19/2021.12%$4,863362.9K
20TARGET GLOBAL ACQUISI I CORP*W EXP 12/08/2021.06%$4,60155.5K
21ALPHA MODUS HLDGS INC*W EXP 12/13/2021.02%$4,44052.2K
22FINNOVATE ACQUISITION CORP*W EXP 09/30/2021.01%$4,36887.3K
23HERAMBA ELEC PLC*W EXP 07/26/2021.00%$4,323101.2K
24EVERGREEN CORPORATION*W EXP 02/08/2020.80%$3,488125.9K
25CONDUIT PHARMACEUTICALS INC*W EXP 09/22/2020.75%$3,272554.6K
26CARMELL CORPORATION*W EXP 07/12/2020.72%$3,12478.1K
27ALURWALLURION TECHNOLOGIES INC*W EXP 08/01/2030.67%$2,90296.7K
28BENFWBENEFICIENT*W EXP 06/07/2020.65%$2,824366.8K
29BANZAI INTERNATIONAL INC*W EXP 12/14/2020.58%$2,504225.6K
30ATEKWATHENA TECHNOLOGY ACQ CORP I*W EXP 10/17/2020.53%$2,294107.7K
31MOUNTAIN & CO I ACQUISITN CO*W EXP 09/30/2020.49%$2,118203.7K
32CALIDI BIOTHERAPEUTICS INC*W EXP 03/14/2020.23%$1,008105.0K
33PPYAWPAPAYA GRWT OPPORTUNITY CORP*W EXP 12/31/2020.23%$1,00550.0K
34CYCUWWESTERN ACQSTN VENTURES CORP*W EXP 99/99/9990.21%$91044.0K
35INTEWINTEGRAL ACQUISITION CORP 1*W EXP 05/31/2020.13%$57657.6K
36MONEYHERO LIMITED*W EXP 09/13/2020.12%$53110.1K
37CACTUS ACQUISITION CORP 1 LT*W EXP 08/17/2020.01%$524.3K
38EVCOWEVEREST CONSOLIDATOR ACQ COR*W EXP 99/99/9990.00%$8400
39DEVVSTREAM CORPCOM0.00%$070.8K

Filing History

QuarterReported ValuePositionsFiledTypeLinks
Q3 2025$01Nov 13, 202513F-HRchanges · EDGAR ↗
Q2 2025$01Aug 14, 202513F-HRchanges · EDGAR ↗
Q1 2025$2,3193May 15, 202513F-HRchanges · EDGAR ↗
Q4 2024$433,43439Feb 13, 202513F-HRchanges · EDGAR ↗
Q3 2024Under review58Nov 13, 202413F-HRchanges · EDGAR ↗
Q2 2024$87M147Aug 14, 202413F-HRchanges · EDGAR ↗
Q1 2024$169M189May 15, 202413F-HRchanges · EDGAR ↗
Q2 2022$192M307Aug 12, 202213F-HRchanges · EDGAR ↗
Q1 2022$234M334Apr 13, 202213F-HRchanges · EDGAR ↗
Q3 2021$190M463Oct 25, 202113F-HRchanges · EDGAR ↗
Q2 2021$193M827Jul 23, 202113F-HRchanges · EDGAR ↗
Q1 2021$127M442May 5, 202113F-HRchanges · EDGAR ↗
Q4 2020$61M245Feb 16, 202113F-HRchanges · EDGAR ↗

13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.